AXS-05, a combination of dextromethorphan and bupropion, led to a rapid and sustained improvement in agitation related to Alzheimer's disease in the phase 3 ACCORD trial.
With voices ringing out in the background, Sandi Lubrant was all smiles sharing how much it meant to bring the Singing Hills Chorus of Mankato, Minnesota, back together for a
A critical shortage of clinicians and front-line workers to support increasing numbers of Alzheimer’s patients is impacting dementia care, advocates say. It’s leaving families with limited options and raising concerns
With voices ringing out in the background, Sandi Lubrant was all smiles sharing how much it meant to bring the Singing Hills Chorus of Mankato, Minnesota, back together for a